Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts.

Amodio G, Moltedo O, Fasano D, Zerillo L, Oliveti M, Di Pietro P, Faraonio R, Barone P, Pellecchia MT, De Rosa A, De Michele G, Polishchuk E, Polishchuk R, Bonifati V, Nitsch L, Pierantoni GM, Renna M, Criscuolo C, Paladino S, Remondelli P.

Front Neurosci. 2019 Jun 27;13:673. doi: 10.3389/fnins.2019.00673. eCollection 2019.

2.

LRP10 variants in Parkinson's disease and dementia with Lewy bodies in the South-West of the Netherlands.

Vergouw LJM, Ruitenberg A, Wong TH, Melhem S, Breedveld GJ, Criscuolo C, De Michele G, de Jong FJ, Bonifati V, van Swieten JC, Quadri M.

Parkinsonism Relat Disord. 2019 May 25. pii: S1353-8020(19)30258-5. doi: 10.1016/j.parkreldis.2019.05.037. [Epub ahead of print]

PMID:
31147221
3.

Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.

Criscuolo C, Cianflone A, Lanzillo R, Carrella D, Carissimo A, Napolitano F, de Cegli R, de Candia P, La Rocca C, Petrozziello T, Matarese G, Boscia F, Secondo A, Di Bernardo D, Brescia Morra V.

Sci Rep. 2019 Mar 12;9(1):4208. doi: 10.1038/s41598-018-38152-8.

4.

Mutations in the SPAST gene causing hereditary spastic paraplegia are related to global topological alterations in brain functional networks.

Rucco R, Liparoti M, Jacini F, Baselice F, Antenora A, De Michele G, Criscuolo C, Vettoliere A, Mandolesi L, Sorrentino G, Sorrentino P.

Neurol Sci. 2019 May;40(5):979-984. doi: 10.1007/s10072-019-3725-y. Epub 2019 Feb 8.

5.

MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis.

Cocozza S, Pontillo G, Lanzillo R, Russo C, Petracca M, Di Stasi M, Paolella C, Vola EA, Criscuolo C, Moccia M, Lamberti A, Monti S, Brescia Morra V, Elefante A, Palma G, Tedeschi E, Brunetti A.

Neuroradiology. 2019 Feb;61(2):155-162. doi: 10.1007/s00234-018-02150-4. Epub 2019 Jan 8.

PMID:
30617409
6.

Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.

Pontillo G, Cocozza S, Lanzillo R, Russo C, Stasi MD, Paolella C, Vola EA, Criscuolo C, Borrelli P, Palma G, Tedeschi E, Morra VB, Elefante A, Brunetti A.

AJNR Am J Neuroradiol. 2019 Jan;40(1):99-106. doi: 10.3174/ajnr.A5915. Epub 2018 Dec 20.

PMID:
30573464
7.

Retinal vascular density in multiple sclerosis: a 1-year follow-up.

Lanzillo R, Cennamo G, Moccia M, Criscuolo C, Carotenuto A, Frattaruolo N, Sparnelli F, Melenzane A, Lamberti A, Servillo G, Tranfa F, De Crecchio G, Brescia Morra V.

Eur J Neurol. 2019 Jan;26(1):198-201. doi: 10.1111/ene.13770. Epub 2018 Sep 3.

PMID:
30102834
8.

LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.

Quadri M, Mandemakers W, Grochowska MM, Masius R, Geut H, Fabrizio E, Breedveld GJ, Kuipers D, Minneboo M, Vergouw LJM, Carreras Mascaro A, Yonova-Doing E, Simons E, Zhao T, Di Fonzo AB, Chang HC, Parchi P, Melis M, Correia Guedes L, Criscuolo C, Thomas A, Brouwer RWW, Heijsman D, Ingrassia AMT, Calandra Buonaura G, Rood JP, Capellari S, Rozemuller AJ, Sarchioto M, Fen Chien H, Vanacore N, Olgiati S, Wu-Chou YH, Yeh TH, Boon AJW, Hoogers SE, Ghazvini M, IJpma AS, van IJcken WFJ, Onofrj M, Barone P, Nicholl DJ, Puschmann A, De Mari M, Kievit AJ, Barbosa E, De Michele G, Majoor-Krakauer D, van Swieten JC, de Jong FJ, Ferreira JJ, Cossu G, Lu CS, Meco G, Cortelli P, van de Berg WDJ, Bonifati V; International Parkinsonism Genetics Network.

Lancet Neurol. 2018 Jul;17(7):597-608. doi: 10.1016/S1474-4422(18)30179-0. Epub 2018 Jun 7.

PMID:
29887161
9.

The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model.

Criscuolo C, Cerri E, Fabiani C, Capsoni S, Cattaneo A, Domenici L.

Neurobiol Aging. 2018 Jul;67:181-188. doi: 10.1016/j.neurobiolaging.2018.03.017. Epub 2018 Mar 23.

PMID:
29735432
10.

Optical coherence tomography angiography detects retinal vascular alterations in different phases of multiple sclerosis.

Lanzillo R, Moccia M, Criscuolo C, Cennamo G.

Mult Scler. 2019 Feb;25(2):300-301. doi: 10.1177/1352458518768060. Epub 2018 Mar 28. No abstract available.

PMID:
29587576
11.

Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations.

Fasano D, Parisi S, Pierantoni GM, De Rosa A, Picillo M, Amodio G, Pellecchia MT, Barone P, Moltedo O, Bonifati V, De Michele G, Nitsch L, Remondelli P, Criscuolo C, Paladino S.

Cell Death Dis. 2018 Mar 7;9(3):385. doi: 10.1038/s41419-018-0410-7.

12.

Visual Evoked Potentials in Glaucoma and Alzheimer's Disease.

Cerri E, Fabiani C, Criscuolo C, Domenici L.

Methods Mol Biol. 2018;1695:69-80. doi: 10.1007/978-1-4939-7407-8_7.

PMID:
29190019
13.

Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.

Schöls L, Rattay TW, Martus P, Meisner C, Baets J, Fischer I, Jägle C, Fraidakis MJ, Martinuzzi A, Saute JA, Scarlato M, Antenora A, Stendel C, Höflinger P, Lourenco CM, Abreu L, Smets K, Paucar M, Deconinck T, Bis DM, Wiethoff S, Bauer P, Arnoldi A, Marques W, Jardim LB, Hauser S, Criscuolo C, Filla A, Züchner S, Bassi MT, Klopstock T, De Jonghe P, Björkhem I, Schüle R.

Brain. 2017 Dec 1;140(12):3112-3127. doi: 10.1093/brain/awx273.

14.

Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis.

Lanzillo R, Cennamo G, Criscuolo C, Carotenuto A, Velotti N, Sparnelli F, Cianflone A, Moccia M, Brescia Morra V.

Mult Scler. 2018 Nov;24(13):1706-1714. doi: 10.1177/1352458517729463. Epub 2017 Sep 21.

PMID:
28933233
15.

CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients.

Carotenuto A, Scalia G, Ausiello F, Moccia M, Russo CV, Saccà F, De Rosa A, Criscuolo C, Del Vecchio L, Brescia Morra V, Lanzillo R.

J Neuroimmunol. 2017 Aug 15;309:47-50. doi: 10.1016/j.jneuroim.2017.05.006. Epub 2017 May 12.

PMID:
28601287
16.

Synaptic Dysfunction in Alzheimer's Disease and Glaucoma: From Common Degenerative Mechanisms Toward Neuroprotection.

Criscuolo C, Fabiani C, Cerri E, Domenici L.

Front Cell Neurosci. 2017 Feb 27;11:53. doi: 10.3389/fncel.2017.00053. eCollection 2017. Review.

17.

Entorhinal Cortex dysfunction can be rescued by inhibition of microglial RAGE in an Alzheimer's disease mouse model.

Criscuolo C, Fontebasso V, Middei S, Stazi M, Ammassari-Teule M, Yan SS, Origlia N.

Sci Rep. 2017 Feb 13;7:42370. doi: 10.1038/srep42370.

18.

The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor.

Capsoni S, Malerba F, Carucci NM, Rizzi C, Criscuolo C, Origlia N, Calvello M, Viegi A, Meli G, Cattaneo A.

Brain. 2017 Jan;140(1):201-217. doi: 10.1093/brain/aww271.

19.

Adult-onset pure tic disorder after post-traumatic hypoxic lesions of the globus pallidus.

Criscuolo C, D'Amico A, Peluso S, Popolizio T, Pellecchia MT.

Parkinsonism Relat Disord. 2017 Jan;34:75-76. doi: 10.1016/j.parkreldis.2016.11.007. Epub 2016 Nov 18. No abstract available.

PMID:
27887894
20.

A customized high-resolution array-comparative genomic hybridization to explore copy number variations in Parkinson's disease.

La Cognata V, Morello G, Gentile G, D'Agata V, Criscuolo C, Cavalcanti F, Cavallaro S.

Neurogenetics. 2016 Oct;17(4):233-244. Epub 2016 Sep 17.

21.

Impulsive-compulsive behaviors in parkin-associated Parkinson disease.

Morgante F, Fasano A, Ginevrino M, Petrucci S, Ricciardi L, Bove F, Criscuolo C, Moccia M, De Rosa A, Sorbera C, Bentivoglio AR, Barone P, De Michele G, Pellecchia MT, Valente EM.

Neurology. 2016 Oct 4;87(14):1436-1441. Epub 2016 Sep 2.

22.

Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Criscuolo C, Procaccini C, Meschini MC, Cianflone A, Carbone R, Doccini S, Devos D, Nesti C, Vuillaume I, Pellegrino M, Filla A, De Michele G, Matarese G, Santorelli FM.

J Neurol. 2015 Dec;262(12):2755-63. doi: 10.1007/s00415-015-7911-4. Epub 2015 Nov 3.

PMID:
26530509
23.

SPG5 and multiple sclerosis: clinical and genetic overlap?

Criscuolo C, Carbone R, Lieto M, Peluso S, Guacci A, Filla A, Quarantelli M, Lanzillo R, Morra VB, De Michele G.

Acta Neurol Scand. 2016 Jun;133(6):410-4. doi: 10.1111/ane.12476. Epub 2015 Sep 15.

PMID:
26370385
24.

A new model to study neurodegeneration in ataxia oculomotor apraxia type 2.

Becherel OJ, Sun J, Yeo AJ, Nayler S, Fogel BL, Gao F, Coppola G, Criscuolo C, De Michele G, Wolvetang E, Lavin MF.

Hum Mol Genet. 2015 Oct 15;24(20):5759-74. doi: 10.1093/hmg/ddv296. Epub 2015 Jul 30.

25.

Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers.

Picillo M, De Rosa A, Pellecchia MT, Criscuolo C, Amboni M, Erro R, Bonifati V, De Michele G, Barone P.

Mov Disord Clin Pract. 2015 Jul 25;2(4):413-416. doi: 10.1002/mdc3.12183. eCollection 2015 Dec.

26.

Impaired synaptic plasticity in the visual cortex of mice lacking α7-nicotinic receptor subunit.

Criscuolo C, Accorroni A, Domenici L, Origlia N.

Neuroscience. 2015 May 21;294:166-71. doi: 10.1016/j.neuroscience.2015.03.022. Epub 2015 Mar 19.

PMID:
25797465
27.

BDNF prevents amyloid-dependent impairment of LTP in the entorhinal cortex by attenuating p38 MAPK phosphorylation.

Criscuolo C, Fabiani C, Bonadonna C, Origlia N, Domenici L.

Neurobiol Aging. 2015 Mar;36(3):1303-9. doi: 10.1016/j.neurobiolaging.2014.11.016. Epub 2014 Dec 2.

PMID:
25554494
28.

Efficacy of dopamine agonist treatment in delayed-onset parkinsonism due to midbrain hemorrhage.

Peluso S, De Rosa A, Antenora A, Lieto M, Criscuolo C, Barbieri F, Pappatà S, De Michele G.

Parkinsonism Relat Disord. 2015 Feb;21(2):156-8. doi: 10.1016/j.parkreldis.2014.10.029. Epub 2014 Nov 21. No abstract available.

PMID:
25483721
29.

A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.

Muona M, Berkovic SF, Dibbens LM, Oliver KL, Maljevic S, Bayly MA, Joensuu T, Canafoglia L, Franceschetti S, Michelucci R, Markkinen S, Heron SE, Hildebrand MS, Andermann E, Andermann F, Gambardella A, Tinuper P, Licchetta L, Scheffer IE, Criscuolo C, Filla A, Ferlazzo E, Ahmad J, Ahmad A, Baykan B, Said E, Topcu M, Riguzzi P, King MD, Ozkara C, Andrade DM, Engelsen BA, Crespel A, Lindenau M, Lohmann E, Saletti V, Massano J, Privitera M, Espay AJ, Kauffmann B, Duchowny M, Møller RS, Straussberg R, Afawi Z, Ben-Zeev B, Samocha KE, Daly MJ, Petrou S, Lerche H, Palotie A, Lehesjoki AE.

Nat Genet. 2015 Jan;47(1):39-46. doi: 10.1038/ng.3144. Epub 2014 Nov 17.

30.

A pharmacogenetic-driven approach for controlled ovarian hyperstimulation by FSH treatment.

Colognato R, Aiello R, Dulcetti F, Ruggeri AM, De Toffol S, Marcato L, Irollo AM, Criscuolo C, Gangale MF, Maggi F, Simoni G.

Minerva Ginecol. 2014 Dec;66(6):543-9.

PMID:
25373014
31.

Cholestenoic acids regulate motor neuron survival via liver X receptors.

Theofilopoulos S, Griffiths WJ, Crick PJ, Yang S, Meljon A, Ogundare M, Kitambi SS, Lockhart A, Tuschl K, Clayton PT, Morris AA, Martinez A, Reddy MA, Martinuzzi A, Bassi MT, Honda A, Mizuochi T, Kimura A, Nittono H, De Michele G, Carbone R, Criscuolo C, Yau JL, Seckl JR, Schüle R, Schöls L, Sailer AW, Kuhle J, Fraidakis MJ, Gustafsson JÅ, Steffensen KR, Björkhem I, Ernfors P, Sjövall J, Arenas E, Wang Y.

J Clin Invest. 2014 Nov;124(11):4829-42. doi: 10.1172/JCI68506. Epub 2014 Oct 1.

32.

RAGE inhibition in microglia prevents ischemia-dependent synaptic dysfunction in an amyloid-enriched environment.

Origlia N, Criscuolo C, Arancio O, Yan SS, Domenici L.

J Neurosci. 2014 Jun 25;34(26):8749-60. doi: 10.1523/JNEUROSCI.0141-14.2014.

33.

PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family.

Olgiati S, De Rosa A, Quadri M, Criscuolo C, Breedveld GJ, Picillo M, Pappatà S, Quarantelli M, Barone P, De Michele G, Bonifati V.

Neurogenetics. 2014 Aug;15(3):183-8. doi: 10.1007/s10048-014-0406-0. Epub 2014 May 10.

PMID:
24816432
34.

Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2.

Fogel BL, Cho E, Wahnich A, Gao F, Becherel OJ, Wang X, Fike F, Chen L, Criscuolo C, De Michele G, Filla A, Collins A, Hahn AF, Gatti RA, Konopka G, Perlman S, Lavin MF, Geschwind DH, Coppola G.

Hum Mol Genet. 2014 Sep 15;23(18):4758-69. doi: 10.1093/hmg/ddu190. Epub 2014 Apr 23.

35.

Genetic screening for the LRRK2 R1441C and G2019S mutations in Parkinsonian patients from Campania.

De Rosa A, De Michele G, Guacci A, Carbone R, Lieto M, Peluso S, Picillo M, Barone P, Salemi F, Laiso A, Saccà F, Tessitore A, Pellecchia MT, Bonifati V, Criscuolo C.

J Parkinsons Dis. 2014;4(1):123-8. doi: 10.3233/JPD-130312.

PMID:
24496098
36.

More on spontaneous regression of chronic lymphocytic leukemia: two new cases and potential role of lamivudine in a further patient with advanced disease and hepatitis B virus infection.

D'Arena G, Guariglia R, Pietrantuono G, Villani O, Martorelli MC, Mansueto G, Criscuolo C, Pierri T, Musto C, Musto P.

Leuk Lymphoma. 2014 Aug;55(8):1955-7. doi: 10.3109/10428194.2013.858151. Epub 2014 Feb 14. No abstract available.

PMID:
24152050
37.

Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa and cataracts (PHARC) screening in an Italian population.

Criscuolo C, Guacci A, Carbone R, Lieto M, Salsano E, Nanetti L, Michele GD, Filla A.

Eur J Neurol. 2013 Apr;20(4):e60. doi: 10.1111/ene.12056. No abstract available.

PMID:
23490117
38.

Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation.

Capsoni S, Amato G, Vignone D, Criscuolo C, Nykjaer A, Cattaneo A.

Biochem Biophys Res Commun. 2013 Feb 15;431(3):579-85. doi: 10.1016/j.bbrc.2013.01.007. Epub 2013 Jan 11.

39.

A case of restless leg syndrome in a family with LRRK2 gene mutation.

De Rosa A, Guacci A, Peluso S, Del Gaudio L, Massarelli M, Barbato S, Criscuolo C, De Michele G.

Int J Neurosci. 2013 Apr;123(4):283-5. doi: 10.3109/00207454.2012.756485. Epub 2013 Feb 4.

PMID:
23227859
40.

SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease.

Capsoni S, Carlo AS, Vignone D, Amato G, Criscuolo C, Willnow TE, Cattaneo A.

J Alzheimers Dis. 2013;33(2):357-71. doi: 10.3233/JAD-2012-121399.

PMID:
22986780
41.

Primary extranodal non-Hodgkin's lymphoma of the vagina: a case report and a review of the literature.

Guastafierro S, Tedeschi A, Criscuolo C, Celentano M, Cobellis L, Rossiello R, Falcone U.

Acta Haematol. 2012;128(1):33-8. doi: 10.1159/000337336. Epub 2012 May 15. Review.

PMID:
22584110
42.

Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis.

Ferrara F, Izzo T, Criscuolo C, Riccardi C, Viola A, Delia R, Carbone A, Celentano M.

Hematol Oncol. 2011 Sep;29(3):139-43. doi: 10.1002/hon.978. Epub 2010 Nov 30.

PMID:
21922508
43.

Motor chip: a comparative genomic hybridization microarray for copy-number mutations in 245 neuromuscular disorders.

Piluso G, Dionisi M, Del Vecchio Blanco F, Torella A, Aurino S, Savarese M, Giugliano T, Bertini E, Terracciano A, Vainzof M, Criscuolo C, Politano L, Casali C, Santorelli FM, Nigro V.

Clin Chem. 2011 Nov;57(11):1584-96. doi: 10.1373/clinchem.2011.168898. Epub 2011 Sep 6.

44.

The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from southern Italy.

Criscuolo C, De Rosa A, Guacci A, Simons EJ, Breedveld GJ, Peluso S, Volpe G, Filla A, Oostra BA, Bonifati V, De Michele G.

Mov Disord. 2011 Aug 1;26(9):1733-6. doi: 10.1002/mds.23735. Epub 2011 Apr 29.

PMID:
21538529
45.

Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndrome.

Ferrara F, Palmieri S, Izzo T, Criscuolo C, Riccardi C.

Hematol Oncol. 2010 Dec;28(4):202-8. doi: 10.1002/hon.943.

PMID:
21136583
46.

Electrophysiological characterisation in hereditary spastic paraplegia type 5.

Manganelli F, Pisciotta C, Dubbioso R, Iodice R, Criscuolo C, Ruggiero L, De Michele G, Santoro L.

Clin Neurophysiol. 2011 Apr;122(4):819-22. doi: 10.1016/j.clinph.2010.10.025. Epub 2010 Dec 15.

PMID:
21111673
47.

Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission.

Ferrara F, Finizio O, Izzo T, Riccardi C, Criscuolo C, Carbone A, Borlenghi E, Rossi G.

Anticancer Res. 2010 Sep;30(9):3845-9.

PMID:
20944181
48.

PRICKLE1 progressive myoclonus epilepsy in Southern Italy.

Criscuolo C, de Leva MF, Sorrentino P, Piro R, Carbone R, Guacci A, De Michele G, Filla A.

Mov Disord. 2010 Nov 15;25(15):2686-7. doi: 10.1002/mds.23350. No abstract available.

PMID:
20842693
49.

Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results.

Ferrara F, Izzo T, Criscuolo C, Riccardi C, Celentano M, Mele G.

Am J Hematol. 2010 Sep;85(9):687-90. doi: 10.1002/ajh.21791.

50.

Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.

Ferrara F, Izzo T, Criscuolo C, Riccardi C, Muccioli G, Viola A, Pane F, Palmieri S.

Biol Blood Marrow Transplant. 2010 Jul;16(7):1018-24. doi: 10.1016/j.bbmt.2010.02.011. Epub 2010 Feb 19.

Supplemental Content

Loading ...
Support Center